Neko Health has raised $700 million in Series C funding as it expands its preventative health model across the UK, Sweden and the US.

CPP Europe’s first statutory accounts show how its UK and Irish clinic acquisitions have been structured, with less than half of the reported headline consideration paid in cash at completion. [1]

Allergan Aesthetics’ new Layered Beauty report suggests consumers are becoming more interested in personalised, multi-treatment journeys — with skin quality, consultation and long-term practitioner relationships playing a growing role.

Blackstone is reportedly exploring a sale of medical-grade skincare brand ZO Skin Health in a deal that could value the business at around $2 billion, highlighting continued investor interest in physician-led skincare.

Healthxchange has secured investment from Growth Partner, giving one of the UK and Ireland’s largest aesthetics distributors fresh backing to support further growth, education and customer services.

Galderma has received European Union approval for Restylane® Shaype™, a high-firmness hyaluronic acid injectable designed specifically for chin augmentation and lower-face shaping.

Skingevity launched in February 2026 with the acquisition of three established UK medical aesthetics clinics, creating a new consolidation platform built around shared infrastructure, governance and clinical independence. [1]

Richards Packaging acquired DermapenWorld for US$40 million in June 2025, moving from Canadian distributor of the microneedling brand to full ownership of the global business.

Harley Academy secured an £8 million investment from Rockpool Investments in February 2024, giving one of the UK’s best-known medical aesthetics training providers fresh capital to expand its education, technology and international reach. [1]

Easyfairs acquired Aesthetics Media in June 2019, bringing the Aesthetics Journal, ACE and the Aesthetics Awards together with CCR under one events and media group. [1]

DD Group acquired UK aesthetics supplier and pharmacy Fox Pharma in February 2026, strengthening its position in medical aesthetics alongside its existing medfx business and expanding its product, training and clinic-support capabilities. [1]

Sinclair Aesthetics has secured EU CE marking for Kytogen® Defend, a new non-animal-derived carboxymethyl chitosan injectable designed to improve skin quality, hydration and superficial tissue appearance.¹

Bridgepoint has expanded its medical aesthetics portfolio with the acquisition of Obagi Medical, adding the skincare brand alongside existing injectables investment Laboratoires Vivacy.

Function Health has secured $450 million in growth financing as it scales a platform combining blood testing, imaging and personalised health intelligence.

Private equity firm Chariot Capital Group completed the acquisition of Laser Clinics UK in June 2026, carving the business out from the wider Laser Clinics Group and positioning it as a standalone UK growth platform. [1]

Harley Academy acquired SkinViva Training Academy in August 2025, extending its medical aesthetics education footprint into Manchester and giving the Rockpool-backed business its first training base in the North of England. [1][2]

InMode’s UK business began as a 51/49 joint venture with Wigmore Medical before the manufacturer acquired the remaining stake in 2021 — a useful case study in how aesthetics brands can move from local partnership to direct ownership.

Bridgepoint completed the acquisition of Vivacy in March 2023, taking control of the French medical aesthetics company behind the Stylage dermal filler range in a transaction valued at approximately €865 million. [1][2]